Remove news alliances
article thumbnail

#news #biotech French biotech investors launch spin-out alliance

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: French biotech investors launch spin-out alliance. from European Biotechnology – first and foremost in European biotech [link].

article thumbnail

#news #biotech Vedanta raises $68M, reveals setback to Bristol Myers alliance

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Vedanta raises $68M, reveals setback to Bristol Myers alliance.Vedanta raises $68M, reveals setback to Bristol Myers alliance ntaylor Wed, 07/21/2021 – 08:16 from FierceBiotech: Biotech [link].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

#news #biotech Insilico puts undruggable cancer targets in its crosshairs with Huadong alliance

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Insilico puts undruggable cancer targets in its crosshairs with Huadong alliance.Insilico puts undruggable cancer targets in its crosshairs with Huadong alliance ntaylor Wed, 09/08/2021 – 08:26 from … Continue reading (..)

article thumbnail

Roche Canada and pCPA conclude talks for Vabysmo eye therapy

Pharmaceutical Technology

Roche Canada has successfully concluded talks with the pan-Canadian Pharmaceutical Alliance (pCPA) for Vabysmo (faricimab injection). Fighting Blindness Canada research and mission programmes director Larissa Moniz stated: “Securing a letter of intent with the pCPA for Vabysmo is incredible news for patients and the vision loss community. “We

Antibody 130
article thumbnail

This week in drug discovery (19-23 June)  

Drug Discovery World

News round-up for 19-23 June by DDW Digital Content Editor Diana Spencer. Advanced Therapy Medicinal Products (ATMPs) have been making the news this week.

article thumbnail

UK, Moderna formalise 10-year vaccines alliance

pharmaphorum

Construction will start early next year of a new manufacturing centre in the UK with the capacity to produce 250 million vaccine doses per year, the centrepiece of a 10-year alliance between the government and US biotech Moderna. The first vaccines are due to be produced at the new facility in 2025.

article thumbnail

How asymmetrical alliances impact firm performance and risk

Scienmag

News from the Journal of Marketing Researchers from University of Georgia, University of South Carolina, and University of Arkansas published a new paper in the Journal of Marketing that analyzes how asymmetries in pre-alliance network ties between a firm and its alliance partner affect the focal firm’s financial performance and financial performance (..)